The ASCO annual meeting is widely considered one of the largest and most prestigious cancer research conferences in the world. From May 30 to June 3, more than 40,000 oncology professionals will ...

Dr. Emre Yekedüz discusses his top 3 key takeaways from attending the 2025 ASCO Genitourinary (GU) Cancers Symposium. Ensuring optimal treatment strategies for renal cell carcinoma (RCC) remains a key ...

In the 1970s and ‘80s, traces of the artist collective Asco, named after the Spanish word for “disgust,” could be seen all over East L.A. The then-teenage creatives pulled all kinds of high ...

Logline: ASCO: Without Permission challenges the limits of documentary conventions to tell the story of a revolutionary Chicano art group who turned 1970s LA into their defiant canvas. Merging ...

February 14, 2025--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that new data presented at the 2025 ASCO Genitourinary Cancers Symposium ...

ASCO posted 2024 pass rates for every optometric institution in the U.S., which highlight both performance and challenges. Image: Adobe Stock According to the Association of Schools and Colleges ...

New SourcePacT solution is the first Isolation Switch to receive UL 3008 Listing for rugged and reliable performance FLORHAM PARK, N.J., Sept. 26, 2024 /PRNewswire/ -- ASCO Power Technologies ...

Please provide your email address to receive an email when new articles are posted on . ASCO’s principles to guide AI in oncology care include transparency, equity and accountability.

Coming into ASCO 2024, what did you consider to be the largest unmet needs in the treatment and management of multiple myeloma (MM)? What are the latest trends and innovations you have observed in ...

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. We’ll resume for ASCO 2025. Well, dear readers. Our ASCO ...

The trial’s results, when presented Sunday, June 2, during the plenary session at the American Society of Clinical Oncology (ASCO) 2024 annual meeting, received a standing ovation from the audience.